Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FMO5 antibody (C-Term)

This anti-FMO5 antibody is a Rabbit Polyclonal antibody detecting FMO5 in WB. Suitable for Human. This Primary Antibody has been cited in 2+ publications.
Catalog No. ABIN1881348

Quick Overview for FMO5 antibody (C-Term) (ABIN1881348)

Target

See all FMO5 Antibodies
FMO5 (Flavin Containing Monooxygenase 5 (FMO5))

Reactivity

  • 40
  • 26
  • 18
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 38
  • 2
Rabbit

Clonality

  • 40
Polyclonal

Conjugate

  • 15
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This FMO5 antibody is un-conjugated

Application

  • 33
  • 15
  • 13
  • 13
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB42789
  • Binding Specificity

    • 15
    • 8
    • 6
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 474-502, C-Term

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This FMO5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 474-502 amino acids from the C-terminal region of human FMO5.

    Isotype

    Ig Fraction
  • Application Notes

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Expiry Date

    6 months
  • Ross, Katzov-Eckert, Dubé, Brooks, Rassekh, Barhdadi, Feroz-Zada, Visscher, Brown, Rieder, Rogers, Phillips, Carleton, Hayden: "Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy." in: Nature genetics, Vol. 41, Issue 12, pp. 1345-9, (2009) (PubMed).

    Furnes, Feng, Sommer, Schlenk: "Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 31, Issue 2, pp. 187-93, (2003) (PubMed).

  • Target

    FMO5 (Flavin Containing Monooxygenase 5 (FMO5))

    Alternative Name

    FMO5

    Background

    Metabolic N-oxidation of the diet-derived amino-trimethylamine (TMA) is mediated by flavin-containing monooxygenase and is subject to an inherited FMO3 polymorphism in man resulting in a small subpopulation with reduced TMA N-oxidation capacity resulting in fish odor syndrome Trimethylaminuria. Three forms of the enzyme, FMO1 found in fetal liver, FMO2 found in adult liver, and FMO3 are encoded by genes clustered in the 1q23-q25 region. Flavin-containing monooxygenases are NADPH-dependent flavoenzymes that catalyzes the oxidation of soft nucleophilic heteroatom centers in drugs, pesticides, and xenobiotics. Alternative splicing results in multiple transcript variants.

    Molecular Weight

    60221

    NCBI Accession

    NP_001138301, NP_001138302, NP_001452

    UniProt

    P49326
You are here:
Chat with us!